Challenges in monoclonal antibody-based therapies (Q37398725)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on January 2009

Language	Label	Description	Also known as
English	Challenges in monoclonal antibody-based therapies	scientific article published on January 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

1 reference

Europe PubMed Central

Challenges in monoclonal antibody-based therapies (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

Seppo Ylä-Herttuala

5

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Diana Schenkwein

3

object named as

Diana Schenkwein

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

4

object named as

Jani K Räty

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

author name string

Haritha Samaranayake

1

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Thomas Wirth

2

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

language of work or name

0 references

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Annals of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

322-331

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Therapeutic monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Intrabodies as drug discovery tools and therapeutics

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Economic aspects of commercial manufacture of biopharmaceuticals

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Therapeutic antibody gene transfer.

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Elimination mechanisms of therapeutic monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Monoclonal antibody-based genetic immunotherapy.

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Antibody targeted drugs as cancer therapeutics

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Challenges in therapeutic glycoprotein production

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by Mammalian cell systems

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Glycosylation of therapeutic proteins in different production systems.

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Current status of antibody therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Stable antibody expression at therapeutic levels using the 2A peptide

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Basic concepts in Q membrane chromatography for large-scale antibody production

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Antibody pharmacokinetics and pharmacodynamics

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Pharmacokinetic aspects of biotechnology products

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

LDL stimulates mitogen-activated protein kinase phosphatase-1 expression, independent of LDL receptors, in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Antibodies and gene therapy: teaching old 'magic bullets' new tricks

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Pharmacokinetics and concentration-effect relationships of therapeutic monoclonal antibodies and fusion proteins

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1.

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Structure-immunogenicity relationships of therapeutic proteins

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Immunotherapy: past, present and future

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Production of human antibody repertoires in transgenic mice

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Stevens-Johnson syndrome after treatment with rituximab

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancers

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Regulatable gene expression systems for gene therapy applications: progress and future challenges

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Cell microencapsulation technology for biomedical purposes: novel insights and challenges

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Encapsulated cell technology: from research to market.

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Immunotherapy of a viral disease by in vivo production of therapeutic monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

In vitro and in vivo secretion of cloned antibodies by genetically modified myogenic cells

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Gene therapy using adenovirus-mediated full-length anti-HER-2 antibody for HER-2 overexpression cancers

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Characterization of adeno-associated virus genomes isolated from human tissues

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Genetic fate of recombinant adeno-associated virus vector genomes in muscle

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody.

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Monoclonal antibodies produced by muscle after plasmid injection and electroporation

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Recombinant adenoviral delivery for in vivo expression of scFv antibody fusion proteins

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation

1 reference

https://api.crossref.org/works/10.1080%2F07853890802698842

21 January 2018

Identifiers

10.1080/07853890802698842

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37398725&oldid=2179819780"